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revolutionize device sterilization in hospital and health care 
settings as well as shift the paradigm of the treatment of 
colonized and/or infected wounds.
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INTRODUCTION: A large animal model for composite 
face transplantation is necessary to better understand the 
immunologic processes and nerve regeneration. Current 
porcine models of facial transplantation fail to include all 
major branches of the facial nerve, and have not demon-
strated long-term survival.1,2 A better understanding and 
detailed evaluation of vascular anatomy and microvascular 
territories in facial subunits and bone can help effectively 
develop a reliable porcine composite tissue flap model for 
experimental reconstructive or transplantation studies.
METHODS: Eleven 10kg domestic pigs were used for 
in-vivo studies. Vascular anatomy was assessed by Intra-
operative anatomical dissections of 11 hemi-facial compos-
ite tissue flaps including the auricle. In addition Computed 
Tomographic Angiography (CTA) and Laser-assisted Indo-
cyanine Green Fluorescence Angiography (LA-ICGFA) 
were used to assess vascular architecture preoperatively and 
flap perfusion. In addition, 8 cadaveric pigs were used for 
selective angiography of branches of the external carotid 
artery using a barium sulfate and latex mixture to provide 
detailed qualitative and quantitative analysis of the vascular 
territories using ultra-high resolution 3D CTA followed by 
a detailed anatomical dissection. Perforator distributions in 
facial subunits and the relationship of vascular territories to 
the facial nerve branches were documented.
RESULTS: A composite tissue flap of the hemi-face 
including the auricle was elevated and auto-transplanted in 
eleven 2 months old domestic pigs. Three pigs underwent 
preoperative CTA. We demonstrated two principal vessels 
supplying the hemifacial tissues: Internal maxillary artery 
(IMA) and superficial temporal artery (STA), with less sig-
nificant contribution from the facial artery. Use of 3D vol-
ume rendering of the CTAs and the anatomical dissections 
demonstrated the vasculature and potential angiosomes of 
dominant and minor branches from the external carotid 
artery. We have been able to categorize facial subunit vas-
cularity to delineate safe vascular territories for flap design 
in facial transplantation or reconstructive surgery.
CONCLUSION: We describe a new swine facial transplan-
tation model with successful outcomes and reliable vascu-
larity confirmed with anatomic, in-vivo CTA studies. Novel 
detailed vascular injection studies provide understanding 
of 3D vascular territories paramount to flap design, there-
fore enabling successful long-term modeling of hemi-facial 
composite tissue transplantation.
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INTRODUCTION: The incidence of acute rejection (AR) 
of the skin within the first year after hand or face transplanta-
tion is approximately 85% and up to 56% of patients experi-
ence multiple episodes1. Significant immunosuppression is 
54
PRS Global Open • 2016
required to prevent allograft loss, and recent studies suggest 
that repeated AR episodes can lead to VCA dysfunction and 
loss2. The mechanisms underlying variability in AR presen-
tation remain poorly defined however.
MATERIALS AND METHODS: 8 cynomolgus mon-
keys received either an orthotopic hand (n=2) or hetero-
topic face VCA (n=6) from MHC-mismatched donors 
following induction with anti-thymocyte globulin. Post-
operatively, triple immunosuppression – tacrolimus, 
mycophenolate mofetil, methylprednisolone – was main-
tained for up to 120 days before bone marrow transplan-
tation (BMT) was performed. Protocol biopsies of VCA 
skin were performed at 30-day intervals for histopathol-
ogy and flow cytometric analysis of resident skin leuko-
cyte populations; VCA-resident cells were differentiated 
by H38 status (mouse antihuman HLA class I monoclo-
nal antibody that cross reacts with cynomolgus monkeys) 
for donor or recipient derivation. Clinical AR was treated 
with steroids and further biopsies were taken for histo-
logic confirmation; corresponding anti-donor responses 
were evaluated by mixed lymphocyte reaction (MLR) and 
allo-antibody formation.
RESULTS: Up to three episodes of AR (from POD 14, 
Banff I to II) developed while recipient animals were 
maintained on triple immunosuppression. Corresponding 
flow cytometric analyses demonstrate > 80% of skin-res-
ident T lymphocytes (CD4+, CD8+) within VCA dermis 
were of recipient origin, suggesting rapid immigration of 
various lineages into the VCA. These observations coin-
cided with the first episode of AR in fully mismatched 
recipients but haplomatched animals remained rejection-
free. All but one episode of AR were successfully treated. 
No allo-antibodies were detected and anti-donor responses 
by MLR were comparable to that against third-party. Fol-
lowing BMT, mixed chimerism was detected and enabled 
immunosuppression withdrawal. However, this was tran-
sient and once lost, clinical AR developed and nearly 
100% of both dermal and epidermal lymphocytes were 
recipient-derived.
CONCLUSION: We report a clinically-relevant model for 
studying AR in VCA. Our results suggest that further under-
standing of the relative importance of MHC differences in 
transplant pairs may lead to differences in outcomes for 
VCA recipients maintained under standard immunosup-
pression. Immunosuppression-free tolerance of non-hema-
topoietic antigens in composite tissues can be achieved, but 
require additional strategies to achieve stable, rather than 
transient mixed chimerism following BMT.
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INTRODUCTION: Tolerance in vascularized composite 
allotransplantation (VCA) remains elusive and patients 
are faced with a lifetime of immunosuppression and asso-
ciated risks. Tocilizumab (anti-IL-6 receptor monoclonal 
antibody) is currently FDA approved for use in rheuma-
toid and idiopathic arthritis. It mitigates inflammation, 
reduces the incidence of GvHD, and is potentially pro-
tolerogenic. We investigated the utility of a short course 
of tocilizumab in a non-human primate model (NHP) 
of facial VCA to achieve prolonged survival and/or 
tolerance.
MATERIALS AND METHODS: VCAs were trans-
planted into MHC-mismatched NHPs (n=4) after induction 
with anti-thymocyte globulin. Post-operative maintenance 
consisted of triple immunosuppression (FK506, meth-
ylprednisolone, MMF) before further conditioning 
(irradiation, lymphocyte depletion) in preparation for co-
stimulatory blockade-based donor bone marrow transplan-
tation (DBMT) on POD 60. Tocilizumab was administered 
on the day of DBMT, and at weekly intervals thereafter for 
